Cell Line Development Market to witness growth of 13% from 2016 to 2023

1. Cell Line Development Market to reach $7.4bn by 2023:Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

2. Key Insights from Cell Line Development Market : • Global Cell Line Development Market is fueled by the development in research activities due to rising prevalence of cancer and auto immune disorders will create more need for cell lines. • Cell line development market is gaining massive business space in the industry due to the growing demand for biosimilars, novel drugs, and vaccines in the biotechnology industry. “Cell culture can be defined as the process by which cells are grown under controlled conditions, generally outside of their natural environment.” • The cell line development market by product is segmented into three main types namely, reagents & media, equipment, and accessories & consumables. • Mammalian and non-mammalian are the two types of sources in the cell line development industry. Within this, the non-mammalian is further classified into insects and amphibians. • Based on cell line; recombinant, primary cell line, hybridomas, and continuous cell line are the four types in the cell line development industry.

3. Continued... • Considering the global trends, North America led the global cell line development industry, owing to enhanced healthcare infrastructure, rinsing awareness regarding cell therapy, and increasing demand for biologics in the U.S. • Asia Pacific cell line development market is witnessing a significant growth due to existence of developing healthcare infrastructure, favorable government policies, rapid economic development. • Latin America cell line development market is foreseen to register a CAGR of 13.3% over the period of 2016-2023. Brazil is another emerging market witnessing healthy growth in the cell line development industry. • Notable companies operating in cell line development industry are Selexis American Type Culture Collection (ATCC), Thermo Fisher Scientific, GE Healthcare, Lonza Group, WuXiAppTec, European Collection of Cell Cultures (ECACC), Sigma-Aldrich Corporation, Sartorious, and Corning.

4. UK Cell Line Development Market size, by Product, 2012-2023 (USD Million)

5. Browse Full Market Research Report On Cell Line Development Market @ http://bit.ly/2xRiQT4 Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/429

6. Table of Content: • Chapter 1. Methodology and Scope • 1.1 Research Methodology • 1.1.1 Initial data exploration • 1.1.2 Statistical model and forecast • 1.1.3 Industry insights and validation • 1.1.4 Research parameters& assumptions • 1.2 Data Sources • 1.2.1 Primary • 1.2.2 Secondary • Chapter 2. Executive Summary • 2.1 Cell Line Development industry 3600 synopsis, 2012 – 2023 (USD Million) • 2.1.1 Business trends • 2.1.2 Application trends • 2.1.3 Service trends • 2.1.4 Usage trends • 2.1.5 Regional trends

7. Table of Content: Chapter 3. Cell Line Development Industry Insights 3.1 Industry segmentation 3.2 Industry size and forecast, 2012 – 2023 (USD Million) 3.3 Industry impact forces 3.3.1 Growth drivers 3.3.1.1 Growing vaccine production 3.3.1.2 Increasing cancer prevalence 3.3.1.3 High biotechnology R&D investments 3.3.1.4 Blockbuster biologics patent expiration 3.3.1.5 Monoclonal antibodies demand 3.3.1.6 Technological innovation 3.3.2 Industry pitfalls & challenges 3.3.2.1 Complex regulatory landscape 3.3.2.2 Concerns regarding stem cell research

8. Table of Content: 3.4 Growth potential analysis 3.5 Porter's analysis 3.6 Cell line development company market share analysis, 2015 3.6.1 Strategy dashboard 3.7 PESTEL analysis

9. Stay In Touch Website: www.gminsights.com Social Media: